Approval · Notice of Compliance 11876 · 2010
VALACYCLOVIR: Notice of Compliance 11876
Issued November 18, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11876
- Date
- November 18, 2010
- Company
- Sorres Pharma IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antiviral agent
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALACYCLOVIR | 02320916 | Cancelled Pre Market |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 500 MG per TAB